Mamta Soni Shares Highlights from CBC Chennai 2026
Mamta Soni, Chief of Laboratory Services at Apollo Health and Lifestyle Limited, shared on LinkedIn:
”The first academic collaboration of 2026 began in Namma Chennai with a very well-attended CBC (Chennai Blood Club) meet today.
The meeting featured excellent interactive sessions, with the highlight being a challenging case of acquired haemophilia in an elderly patient on Hemlibra (emicizumab).
The discussion focused on how emicizumab interferes with routine clot based coagulation assays causing spurious shortening of APTT, falsely elevated Factor VIII levels, and unreliable Bethesda assays, making conventional monitoring of acquired hemophilia therapy almost impossible .
In patients on a Emicizumab, FVIII assays must be performed using bovine factors, two-step chromogenic methods.
Chromogenic FVIII assays provide accurate results in patients on emicizumab, whereas clot-based assays yield falsely normal values due to drug interference.
It gives me immense clinical satisfaction that we at the CRL Coagulation Laboratory were able to rapidly decode the puzzle, supporting both the clinician and, most importantly, the patient.
This case also strongly emphasized the critical importance of laboratories being aware of the patient’s clinical background and ongoing therapy before performing and interpreting coagulation tests.
Other stimulating cases discussed included:
* LAHPS syndrome (Lupus anticoagulant-hypoprothrombinemia syndrome )
* T-ALL: transplant decision-making using single-cell genomic data
* Renal amyloidosis spotter images
Overall, it was a rich clinical and academic feast, reinforcing the power of close clinician–laboratory collaboration.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation